(Q23920926)

American Journal of Respiratory and Critical Care Medicine

16 January 2020

language of work or name

English

0 references

publication date

December 1997

0 references

published in

0 references

volume

156

0 references

issue

6

0 references

page(s)

1884-1891

0 references

1884-91

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

cites work

Cellular and molecular aspects of granulomatous inflammation

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Cytokines and airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Metal-induced infidelity during DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Binding of beryllium to nuclear acidic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

The inhibition of enzymes by beryllium

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

Circulating interleukin-6 receptor in patients with sepsis syndrome

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

Studies on the structure and regulation of the human hepatic interleukin-6 receptor

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

Compartmentalized immune response reflects clinical severity of beryllium disease

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021

Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.156.6.9610040

7 January 2021